Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis

Inflammation Research

Volumn 48, Issue 1, 1999, Pages 48-55

  Joosten, L A B ^a   Helsen, M M A ^a   Saxne, T ^b,c   Heinegard D ^c   Van De Putte, L B A ^a   Van Den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Cartilage destruction; Collagen induced arthritis; COMP levels; IL 10; Prednisolone

Indexed keywords

COLLAGEN; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MATRIX PROTEIN; MESSENGER RNA; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG POTENTIATION; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SCORING SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; CATTLE; COLLAGEN; CYTOKINES; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; INTERLEUKIN-10; MALE; MICE; MICE, INBRED DBA; PREDNISOLONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL FLUID;

EID: 0032971560     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050396     Document Type: Article

References (38)

1. [1] Fiorentine DF, Bond MW, Mosmann TR. Two types of mouse T helper cell.IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
2. [2] Moore KW, O'Garra A, De Waal-Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
3. [3] De Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
4. [4] Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits the cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
5. [5] Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995; 96:2304-10.
6. [6] Scheiman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.
7. [7] Auphan N, Didonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by Glucocorticoids: Inhibition of NF-kB activity through induction of IkB synthesis. Science 1995;270: 286-90.
8. [8] Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rgeumatoid arthritis. Arthritis Rheum 1995;38:151-60.
9. [9] Bucala R, Ritchlin C, Winchester R, Cerami A. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 1991;173:569-74.
10. [10] Elliot MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen J, et al. Randomised double-blind comparision of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatiod arthritis. Lancet 1994;344:1105-10.
11. [11] Rankin ECC, Choy EHS, Kassimos D, Kingsly GH, Sopwith AM, Isenberg DA, et al. The therapeutic effects of an engineered human anti-tumour necrosis factor α antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol 1995;34:334-42.
12. [12] Vannier E, Miller LC, Dinarello CA. Coordinated anti-inflammatory effects of interleukin-4: IL-4 suppresses IL-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist. Proc Natl Acad Sci USA, 1992;89:4076-80.
13. [13] Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulaled human polymorpho-nuclear leukocytes by delaying mRNA degradation. J Exp Med 1994;179:1695-99.
14. [14] Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, et al. Balance of IL-1 receptor antagonist/IL-1ß in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995;154:1432-39.
15. [15] Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Prod Natl Acad Sci USA 1992;89:9784-88.
16. [16] Joosten LAB, Helsen MMA, Van de Loo AJJ, Van den Berg WB. Anti-cytokine treatment of established collagen type II arthritis in DBA/1 mice: A comparative study using anti-TNF alpha, anti-IL-1 alpha, beta and IL-1Ra. Arthritis Rheum 1996; 39:797-809.
17. [17] Joosten LAB, Lubberts E, Durez P, Helsen MMA, Jacobs MJ, Goldman M, et al. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 1997;40:249-60.
18. [18] Saxne T, Heinegård D. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol 1992;31:583-91.
19. [19] Miller EJ, Rhodes RK. Preparation and characterization of the different types of collagen. Methods Enzymol 1982;2:33-65.
20. [20] Lubberts E, Joosten LAB, Helsen MMA, Van den Berg WB. Regulatory role of interleukin-10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. Cytokine 1998;10:361-69.
21. [21] Larsson E, Mussener Å, Heinegård D, Klareskog L, Saxne T. Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br J Rheumatol 1997;36:1258-61.
22. [22] Vingsbo-Lundberg C, Saxne T, Olsson H, Holmdahl R. Increased serum levels of cartilage oligomeric matrix protein in chronic erosive arthritis in rats. Arthritis Rheum 1998;41:544-50.
23. [23] Van Meurs JBJ, Van Lent PLEM, Joosten LAB, Van de Kraan PM, Van den Berg WB. Quantification of mRNA levels in joint capsule and articular cartilage on the murine knee joint by RT-PCR. Rheum Int 1997;16:197-203.
24. [24] Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
25. [25] Kanangat S, Blair P, Reddy R, Deheshia M, Godfrey V, Rose BT, et al. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur. J Immunol 1996;26:161-7.
26. [26] Van den Berg WB, Joosten LAB, Van de Putte LBA. Electrical charge of the antigen determines intraarticular handling and chronicity of arthritis in mice. J Clin Invest 1984;74:1850-9.
27. [27] Joosten LAB, Helsen MMA, Van den Berg WB. Accelerated onset of collagen-induced arthritis by remote inflammation. Clin Exp Immunol 1994;97:204-11.
28. [28] Ku G, Faust T, Lauffer LL, Livingston DJ, Harding MW. Interleukin-1ß converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 1996;8:377-86.
29. [29] Mori L, Iselin S, Delibero G, Lesslauer W. Attenuation of collagen induced arthritis in 55kDa TNF receptor type 1 (TNFRI) TgG1 treated and TNFR1 deficient mice. J Immunol 1996;157:3178-82.
30. [30] Kunicka JE, Talle MA, Denhardt GH, Brown M, Prince LA, Goldstein G. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol 1993;149:39-49.
31. [31] Joyce DA, Steer JH, Kloda A. Dexamethasone antagonizes IL-4 and IL-10-induced release of IL-1RA by monocytes but augments IL-4, IL-10 and TGFß induced suppression of TNFα release. J Interferon Cytokine Res 1996;16:511-7.
32. [32] Van de Loo AAJ, Arntz OJ, Enckevort FHJ, Van Lent PLEM, Van den Berg WB. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS-2 deficient mice and in antiinterleukin-1 treated wild type mice with unabated joint inflammation. Arthritis Rheum 1998;41:634-46.
33. [33] Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, et al. IL-10 inhibition of the progression of established collagen induced arthritis. Arthritis Rheum 1996;39:495-503.
34. [34] Joosten LAB, Lubberts E, Helsen MMA, Van den Berg WB. Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol 1997;159:4094-102.
35. [35] Meyaard L, Hovenkamp E, Otto SA, Miedema F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 1996;156:2777-82.
36. [36] Joosten LAB, Helsen MMA, Van den Berg WB. Protective effect of rimexolone on cartilage damage in arthritic mice: a comparative study with triamcinolon hexacetonide. Agents Actions 1990;31:135-42.
37. [37] Månsson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, et al. Cartilage and bone metabolism in rheumatoid arthritis. J Clin Invest 1995;95:1071-7.
38. [38] Di Cesare PE, Carlson CS, Stollerman ES, Chen FS, Leslie M, Perris R. Expression of cartilage oligomeric matrix protein by human synovium. FEBS Lett 1997;412:249-52.